Das; Bhaskar C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Das; Bhaskar C..The latest application filed is for "small molecule analogs of the protein e4orf1 in the treatment and prevention of metabolic disorders".

Company Profile

2.14.16

Das; Bhaskar C. - Lubbock TX
DAS; Bhaskar C. - Kansas City KS
Das; Bhaskar C. - West Nyack NY
Das; Bhaskar C. - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Small Molecule Analogs Of The Protein E4ORF1 In The Treatment And Prevention Of Metabolic Disorders App 20220071953 - Dhurandhar; Nikhil V. ; et al.	2022-03-10
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof App 20210053958 - CUERVO; Ana Maria ; et al.	2021-02-25
Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof Grant 10,766,886 - Cuervo , et al. Sep	2020-09-08
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof App 20190225599 - CUERVO; Ana Maria ; et al.	2019-07-25
Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof Grant 10,189,827 - Cuervo , et al. Ja	2019-01-29
Small molecule analogs of E4orf1 Grant 10,047,107 - Das , et al. August 14, 2	2018-08-14
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof App 20180141937 - Cuervo; Ana Maria ; et al.	2018-05-24
Compositions and methods for improving glucose uptake Grant 9,714,259 - Dhurandhar , et al. July 25, 2	2017-07-25
Compositions And Methods For Improving Glucose Uptake App 20170044189 - Dhurandhar; Nikhil V. ; et al.	2017-02-16
SMALL MOLECULE ANALOGS OF E4orf1 App 20170037064 - DAS; Bhaskar C. ; et al.	2017-02-09
Retinoic Acid Receptor Antagonists As Chaperone-mediated Authophagy Modulators And Uses Thereof App 20170037039 - Cuervo; Ana Maria ; et al.	2017-02-09
Retinoic acid receptor antagonists as chaperone-mediated autophagy modulators and uses thereof Grant 9,512,092 - Cuervo , et al. December 6, 2	2016-12-06
Compositions and methods for improving glucose uptake Grant 9,469,659 - Dhurandhar , et al. October 18, 2	2016-10-18
Compositions and methods for improving glucose uptake Grant 9,346,835 - Dhurandhar , et al. May 24, 2	2016-05-24
Compositions And Methods For Improving Glucose Uptake App 20160113951 - Dhurandhar; Nikhil V. ; et al.	2016-04-28
Compositions And Methods For Improving Glucose Uptake App 20150266903 - Dhurandhar; Nikhil V. ; et al.	2015-09-24
Retinoic Acid Receptor Antagonists As Chaperone-mediated Autophagy Modulators And Uses Thereof App 20150166492 - CUERVO; ANA MARIA ; et al.	2015-06-18
Ketoconazole-derivative antagonist of human pregnane X receptor and uses thereof Grant 8,669,260 - Mani , et al. March 11, 2	2014-03-11
Novel Lipogenic Inhibitors And Uses Thereof App 20140051661 - Das; Bhaskar C. ; et al.	2014-02-20
Mitochondrial inhibitors to treat human disease Grant 8,581,005 - Jubinsky , et al. November 12, 2	2013-11-12
Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents Grant 8,460,635 - Kalpana , et al. June 11, 2	2013-06-11
Aryl Bidentate Isonitriles and Their Uses App 20110236308 - Elmaleh; David R. ; et al.	2011-09-29
Ketoconazole-derivative Antagonist Of Human Pregnane X Receptor And Uses Thereof App 20110105522 - Mani; Sridhar ; et al.	2011-05-05
Fenretinide Derivatives And Uses Thereof As Therapeutic, Diagnostic And Imaging Agents App 20110091383 - Kalpana; Ganjam V. ; et al.	2011-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.